Treceți offline cu aplicația Player FM !
Podcasturi care merită ascultate
SPONSORIZAT
![Mind The Business: Small Business Success Stories podcast artwork](https://cdn.player.fm/images/44159763/series/yvoDOHutf1eKJqQp/32.jpg 32w, https://cdn.player.fm/images/44159763/series/yvoDOHutf1eKJqQp/64.jpg 64w, https://cdn.player.fm/images/44159763/series/yvoDOHutf1eKJqQp/128.jpg 128w, https://cdn.player.fm/images/44159763/series/yvoDOHutf1eKJqQp/256.jpg 256w, https://cdn.player.fm/images/44159763/series/yvoDOHutf1eKJqQp/512.jpg 512w)
![Mind The Business: Small Business Success Stories podcast artwork](/static/images/64pixel.png)
1 The SB Starter Kit - Everything You Need or Need to Know to Get Your Business Off the Ground (Part 1) - Trademarks, Patents, LLCs and SCorps 35:28
Emmy Boerrigter on dose selection of novel anticancer drugs
Manage episode 431363805 series 2829082
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00134-7?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 episoade
Manage episode 431363805 series 2829082
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00134-7?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 episoade
Toate episoadele
×![Artwork](/static/images/128pixel.png)
1 Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 18:03
![Artwork](/static/images/128pixel.png)
1 Yannick Romero on the changing landscape of national cancer control plans 24:40
![Artwork](/static/images/128pixel.png)
1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15
![Artwork](/static/images/128pixel.png)
1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07
![Artwork](/static/images/128pixel.png)
1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21
![Artwork](/static/images/128pixel.png)
1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45
![Artwork](/static/images/128pixel.png)
1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22
![Artwork](/static/images/128pixel.png)
1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41
![Artwork](/static/images/128pixel.png)
1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56
![Artwork](/static/images/128pixel.png)
1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08
![Artwork](/static/images/128pixel.png)
1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05
![Artwork](/static/images/128pixel.png)
1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22
![Artwork](/static/images/128pixel.png)
1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
![Artwork](/static/images/128pixel.png)
1 Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 34:43
![Artwork](/static/images/128pixel.png)
1 Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 16:06
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma 13:53
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Neerja Bhatla on a new quadrivalent HPV vaccine 12:24
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery 43:49
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma 17:10
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Wanda Cui on measuring ovarian toxicity 10:37
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA 12:31
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma 33:50
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Madeline Pe on the SISAQOL initiative 14:01
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children 28:40
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Mark Lythgoe on UK oncology drug approval after Brexit 14:11
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Janet Brown on the phase 2/3 STAR trial 20:43
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Valerie Speirs on biomarkers in male breast cancer 17:40
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Sameer Bakhshi on sex disparities in childhood cancer in India 23:02
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.